D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 17 520 KRW 7.03%
Market Cap: 770.2B KRW
Have any thoughts about
Dongkook Pharmaceutical Co Ltd?
Write Note

Dongkook Pharmaceutical Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dongkook Pharmaceutical Co Ltd
Total Equity Peer Comparison

Comparables:
000100
326030
128940
S
000250
C
068760

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
D
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Total Equity
â‚©558.6B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
13%
Yuhan Corp
KRX:000100
Total Equity
â‚©2.1T
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
5%
SK Biopharmaceuticals Co Ltd
KRX:326030
Total Equity
â‚©283.7B
CAGR 3-Years
-9%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Total Equity
â‚©1.1T
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
7%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Total Equity
â‚©276.5B
CAGR 3-Years
15%
CAGR 5-Years
13%
CAGR 10-Years
11%
C
Celltrion Pharm Inc
KOSDAQ:068760
Total Equity
â‚©381B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
8%

See Also

What is Dongkook Pharmaceutical Co Ltd's Total Equity?
Total Equity
558.6B KRW

Based on the financial report for Jun 30, 2024, Dongkook Pharmaceutical Co Ltd's Total Equity amounts to 558.6B KRW.

What is Dongkook Pharmaceutical Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
13%

Over the last year, the Total Equity growth was 7%. The average annual Total Equity growth rates for Dongkook Pharmaceutical Co Ltd have been 9% over the past three years , 11% over the past five years , and 13% over the past ten years .

Back to Top